Clinical Trials Directory

Trials / Completed

CompletedNCT03525912

Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions

Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions: a Prospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Universidad de Antioquia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluation of neuropsychiatric and cardiovascular side effects of low dose ketamine analgesic infusion for postoperative pain

Detailed description

Postoperative pain is a world wide problem related with surgery. Multimodal analgesia may include ketamine, aimed to decrease opioid adverse effects in postoperative analgesia for major surgery, and risk of chronic postsurgical pain. Ketamine has shown efficacy as adjuvant in multimodal analgesia, however, neuropsychiatric and cardiovascular effects of ketamine at low doses in continue postoperative infusion are less known. This type of adverse effects may compromise appropriated recovery. Objective to determine frequency of delirium, agitation, sedation, hallucinations, bad dreams and cardiovascular changes associated with ketamine analgesic infusion treatment for postoperative pain.

Conditions

Interventions

TypeNameDescription
DRUGKetaminecontinuous infusion of low dose ketamine for postoperative pain

Timeline

Start date
2017-07-01
Primary completion
2018-03-31
Completion
2018-11-14
First posted
2018-05-16
Last updated
2019-03-28

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT03525912. Inclusion in this directory is not an endorsement.